作者
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, PJ Devereaux, Victor M Montori, Bo Freyschuss, Gunn Vist, Roman Jaeschke, John W Williams Jr, Mohammad Hassan Murad, David Sinclair, Yngve Falck-Ytter, Joerg Meerpohl, Craig Whittington, Kristian Thorlund, Jeff Andrews, Holger J Schünemann
发表日期
2011/12/1
期刊
Journal of clinical epidemiology
卷号
64
期号
12
页码范围
1283-1293
出版商
Pergamon
简介
GRADE suggests that examination of 95% confidence intervals (CIs) provides the optimal primary approach to decisions regarding imprecision. For practice guidelines, rating down the quality of evidence (i.e., confidence in estimates of effect) is required if clinical action would differ if the upper versus the lower boundary of the CI represented the truth. An exception to this rule occurs when an effect is large, and consideration of CIs alone suggests a robust effect, but the total sample size is not large and the number of events is small. Under these circumstances, one should consider rating down for imprecision. To inform this decision, one can calculate the number of patients required for an adequately powered individual trial (termed the “optimal information size” [OIS]). For continuous variables, we suggest a similar process, initially considering the upper and lower limits of the CI, and subsequently calculating an OIS …
引用总数
20122013201420152016201720182019202020212022202320243776115175200187197210215290297257179
学术搜索中的文章
GH Guyatt, AD Oxman, R Kunz, J Brozek… - Journal of clinical epidemiology, 2011